Filing Flows › Roivant Sciences (ROIV) › Q4 FY26 › vs Q3 FY26
Roivant Sciences (ROIV) Q4 FY26 vs Q3 FY26 (quarter over quarter)
Roivant Sciences's revenue rose $521K (+26%) from $2.0M in Q3 FY26 to $2.5M in Q4 FY26.
Roivant Sciences, Q4 FY26: revenue $2.5M (-67% year over year), net earnings $303M, operating cash flow −$164M. The chart draws each line against Q3 FY26, the increases inside each band.
Every line
| Line | Q4 FY26 | Q3 FY26 | Change | % |
|---|---|---|---|---|
| Revenue | $2.5M | $2.0M | $521K | +26% |
| Other income, net | $38.9M | $48.8M | −$9.9M | -20% |
| Operating profit | $415M | −$339M | $754M | — |
| Pre-tax earnings | $454M | −$290M | $744M | — |
| Net earnings | $303M | −$266M | $569M | — |
| Minority interests | $52.8M | −$47.8M | $101M | — |
| Income tax | $98.4M | $23.3M | $75.0M | +322% |
| Operating cash sources | $545M | $36.3M | $508M | 15× |
| Depreciation & amortization | $638K | $691K | −$53K | -8% |
| Share-based compensation | $77.2M | $105M | −$27.8M | -27% |
| Cash used in operations | $164M | $196M | −$32.7M | -17% |
| Working capital & other | $545M | $36.3M | $508M | 15× |
Questions
How much did Roivant Sciences's revenue grow quarter over quarter in Q4 FY26?
Roivant Sciences's revenue rose $521K (+26%) from $2.0M in Q3 FY26 to $2.5M in Q4 FY26.